{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:22:04Z","timestamp":1791037324385,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Idiopathic myelofibrosis (IM) is a disease characterized by marrow fibrosis, abnormal stem\/progenitor cell trafficking, and extramedullary hematopoiesis frequently associated with alterations in megakaryocytes (Mks). Mice harboring genetic alterations in either the extrinsic (ectopic thrombopoietin expression, TPOhigh mice) or intrinsic (hypomorphic GATA-1 mutation, GATA-1low mice) control of Mk differentiation develop myelofibrosis, a syndrome similar to IM. The relationship, if any, between the pathobiologic mechanism leading to the development of myelofibrosis in the 2 animal models is not understood. Here we show that plasma from GATA-1low mice contained normal levels of TPO. On the other hand, Mks from TPO-treated wild-type animals (TPOhigh mice), as those from GATA-1low animals, had similar morphologic abnormalities and contained low GATA-1. In both animal models, development of myelofibrosis was associated with high transforming growth factor \u03b21 (TGF-\u03b21) content in extracellular fluids of marrow and spleen. Surprisingly, TPO treatment of GATA-1low mice restored the GATA-1 content in Mks and halted both defective thrombocytopoiesis and fibrosis. These data indicate that the TPOhigh and GATA-1low alterations are linked in an upstream-downstream relationship along a pathobiologic pathway leading to development of myelofibrosis in mice and, possibly, of IM in humans.<\/jats:p>","DOI":"10.1182\/blood-2004-04-1320","type":"journal-article","created":{"date-parts":[[2005,1,22]],"date-time":"2005-01-22T01:46:06Z","timestamp":1106358366000},"page":"3493-3501","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":99,"title":["A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-\u03b21 in the development of myelofibrosis"],"prefix":"10.1182","volume":"105","author":[{"given":"Alessandro M.","family":"Vannucchi","sequence":"first","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bianchi","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paoletti","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pancrazzi","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Torre","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zingariello","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Di Baldassarre","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Alba","family":"Rana","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Lorenzini","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Alfani","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Migliaccio","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Migliaccio","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Experimental Pathology and Oncology, University of Florence, Florence Italy; Kirin Brewery Pharmaceutical Research Laboratory, Gunma, Japan; the Department of Biomorphology, University of Chieti, Rome, Italy; and the Quality and Safety of Animal Experimentation and the Departments of Cell Biology and Neurosciences and Hematology, Oncology, and Molecular Medicine, Istituto Superiore Sanita\u0300, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222433055800_REF1","doi-asserted-by":"crossref","unstructured":"Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17: 2954-2970.","DOI":"10.1200\/JCO.1999.17.9.2954"},{"key":"2020021222433055800_","doi-asserted-by":"crossref","unstructured":"Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342: 1255-1265.","DOI":"10.1056\/NEJM200004273421706"},{"key":"2020021222433055800_REF3","unstructured":"Hoffman R. Agnogenic myeloid metaplasia. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology: Basic principles and practice. 3rd ed. New York, NY: Churchill Livingstone; 2000:1172- 1188."},{"key":"2020021222433055800_REF4","doi-asserted-by":"crossref","unstructured":"Yan XQ, Lacey D Fletcher C, et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood. 1995;86: 4025-4033.","DOI":"10.1182\/blood.V86.11.4025.bloodjournal86114025"},{"key":"2020021222433055800_REF5","doi-asserted-by":"crossref","unstructured":"Yan XQ, Lacey D, Hill D, et al. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood. 1996;88: 402-409.","DOI":"10.1182\/blood.V88.2.402.bloodjournal882402"},{"key":"2020021222433055800_","doi-asserted-by":"crossref","unstructured":"Guardiola P, Esperou H, Cazals-Hatem D, et al. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia: French Society of Bone Marrow Transplantation. Br J Haematol. 1997;98: 1004-1009.","DOI":"10.1046\/j.1365-2141.1997.3073124.x"},{"key":"2020021222433055800_","doi-asserted-by":"crossref","unstructured":"Devine SM, Hoffman R, Verma A, et al. Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002;99: 2255-2258.","DOI":"10.1182\/blood.V99.6.2255"},{"key":"2020021222433055800_REF8","doi-asserted-by":"crossref","unstructured":"Deeg HJ, Gooley TA, Flowers ME, et al. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood. 2003;102: 3912-3918.","DOI":"10.1182\/blood-2003-06-1856"},{"key":"2020021222433055800_REF9","unstructured":"Castro-Malaspina H. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Prog Clin Biol Res. 1984;154: 427-454."},{"key":"2020021222433055800_REF10","doi-asserted-by":"crossref","unstructured":"Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86: 419-431.","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419"},{"key":"2020021222433055800_REF11","doi-asserted-by":"crossref","unstructured":"Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001;19: 397-407.","DOI":"10.1634\/stemcells.19-5-397"},{"key":"2020021222433055800_REF12","unstructured":"Orkin SH. Transcription factors that regulate lineage decisions. In: Stamatoyannopoulous G, ed. The Molecular Basis of Blood Diseases. Philadelphia PA: WB Saunders; 2000: 80-120."},{"key":"2020021222433055800_REF13","doi-asserted-by":"crossref","unstructured":"Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood. 2004;103: 399-406.","DOI":"10.1182\/blood-2003-05-1556"},{"key":"2020021222433055800_REF14","doi-asserted-by":"crossref","unstructured":"Shivdasani RA, Fujiwara Y, McDevitt MA, et al. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. Embo J. 1997;16: 3965-3973.","DOI":"10.1093\/emboj\/16.13.3965"},{"key":"2020021222433055800_REF15","doi-asserted-by":"crossref","unstructured":"Zhou W, Toombs CF, Zou T, et al. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood. 1997;89: 1551-1559.","DOI":"10.1182\/blood.V89.5.1551"},{"key":"2020021222433055800_REF16","doi-asserted-by":"crossref","unstructured":"Villeval JL, Cohen-Solal K, Tulliez M, et al. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood. 1997;90: 4369-4383.","DOI":"10.1182\/blood.V90.11.4369"},{"key":"2020021222433055800_REF17","doi-asserted-by":"crossref","unstructured":"Yanagida M, Ide Y, Imai A, et al. The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats. Br J Haematol. 1997;99: 739-745.","DOI":"10.1046\/j.1365-2141.1997.4843288.x"},{"key":"2020021222433055800_REF18","doi-asserted-by":"crossref","unstructured":"Vyas P, Ault K, Jackson CW, et al. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 1999;93: 2867-2875.","DOI":"10.1182\/blood.V93.9.2867"},{"key":"2020021222433055800_REF19","doi-asserted-by":"crossref","unstructured":"McDevitt MA, Shivdasani RA, Fujiwara Y, et al. A \u201cknockdown\u201d mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A. 1997;94: 6781-6785.","DOI":"10.1073\/pnas.94.13.6781"},{"key":"2020021222433055800_REF20","doi-asserted-by":"crossref","unstructured":"Vannucchi AM, Bianchi L, Cellai C, et al. Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1low mice). Blood. 2001;97: 3040-3050.","DOI":"10.1182\/blood.V97.10.3040"},{"key":"2020021222433055800_REF21","doi-asserted-by":"crossref","unstructured":"Vannucchi AM, Bianchi L, Cellai C, et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice). Blood. 2002;100: 1123-1132.","DOI":"10.1182\/blood-2002-06-1913"},{"key":"2020021222433055800_REF22","doi-asserted-by":"crossref","unstructured":"Centurione L, Di Baldassarre A, Zingariello M, et al. Increased and pathological emperipolesis of neutrophils within megakaryocites associated with marrow fibrosis in GATA-1low mice. Prepublished on August 3, 2004, as DOI 10.1182\/blood-2004-01-0193. (Now available as Blood. 2004;104: 3573-3580).","DOI":"10.1182\/blood-2004-01-0193"},{"key":"2020021222433055800_REF23","unstructured":"Papayannopoulou T, Abkowitz J, D'Andrea A, Migliaccio AR. Biology of erythropoiesis, erythroid differentiation and maturation. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology: Basic principles and practice. 4th ed. New York, NY: Churchill Livingstone; 2003: 267-288."},{"key":"2020021222433055800_REF24","doi-asserted-by":"crossref","unstructured":"Zon LI, Youssoufian H, Mather C, et al. Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A. 1991;88: 10638-10641.","DOI":"10.1073\/pnas.88.23.10638"},{"key":"2020021222433055800_REF25","doi-asserted-by":"crossref","unstructured":"De Maria R, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 1999;401: 489-493.","DOI":"10.1038\/46809"},{"key":"2020021222433055800_REF26","doi-asserted-by":"crossref","unstructured":"Migliaccio AR, Rana RA, Sanchez M, et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med. 2003;197: 281-296.","DOI":"10.1084\/jem.20021149"},{"key":"2020021222433055800_REF27","doi-asserted-by":"crossref","unstructured":"Williams N, Eger RR, Jackson HM, et al. Two-factor requirement for murine megakaryocyte colony formation. J Cell Physiol. 1982;110: 101-104.","DOI":"10.1002\/jcp.1041100116"},{"key":"2020021222433055800_REF28","doi-asserted-by":"crossref","unstructured":"Beham-Schmid C, Apfelbeck U, Sill H, et al. Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. Blood. 2002;99: 381-383.","DOI":"10.1182\/blood.V99.1.381"},{"key":"2020021222433055800_REF29","doi-asserted-by":"crossref","unstructured":"Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood. 2002;100: 3495-3503.","DOI":"10.1182\/blood-2002-04-1133"},{"key":"2020021222433055800_REF30","unstructured":"Sambrook J, Fritsch, EF, Maniatis, T. Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989."},{"key":"2020021222433055800_REF31","doi-asserted-by":"crossref","unstructured":"Ulich TR, del Castillo J, Senaldi G, et al. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood. 1996;87: 5006-5015.","DOI":"10.1182\/blood.V87.12.5006.bloodjournal87125006"},{"key":"2020021222433055800_REF32","doi-asserted-by":"crossref","unstructured":"Schmitt A, Jouault H, Guichard J, et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood. 2000;96: 1342-1347.","DOI":"10.1182\/blood.V96.4.1342"},{"key":"2020021222433055800_REF33","doi-asserted-by":"crossref","unstructured":"Terui T, Niitsu Y, Mahara K, et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood. 1990;75: 1540-1548.","DOI":"10.1182\/blood.V75.7.1540.1540"},{"key":"2020021222433055800_REF34","doi-asserted-by":"crossref","unstructured":"Le Bousse-Kerdile\u0300s MC, Chevillard S, Charpentier A, et al. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 1996;88: 4534-4546.","DOI":"10.1182\/blood.V88.12.4534.bloodjournal88124534"},{"key":"2020021222433055800_REF35","doi-asserted-by":"crossref","unstructured":"Grass JA, Boyer ME, Pal S, et al. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A. 2003;100: 8811-8816.","DOI":"10.1073\/pnas.1432147100"},{"key":"2020021222433055800_REF36","doi-asserted-by":"crossref","unstructured":"Vyas P, McDevitt MA, Cantor AB, et al. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development. 1999;126: 2799-2811.","DOI":"10.1242\/dev.126.12.2799"},{"key":"2020021222433055800_REF37","doi-asserted-by":"crossref","unstructured":"Papayannopoulou T. Bone marrow homing: the players, the playfield, and their evolving roles. Curr Opin Hematol. 2003;10: 214-219.","DOI":"10.1097\/00062752-200305000-00004"},{"key":"2020021222433055800_REF38","unstructured":"Vannucchi A, Bianchi, L, Pancrazzi, A, et al. Reduced GATA-1 content in megakaryocytes of patients with idiopathic myelofibrosis [abstract]. Blood. 2004;102: 2457."},{"key":"2020021222433055800_REF39","doi-asserted-by":"crossref","unstructured":"Thiele J, Lorenzen J, Manich B, et al. Apoptosis (programmed cell death) in idiopathic (primary) osteo-\/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol. 1997;97: 137-143.","DOI":"10.1159\/000203671"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3493\/1709399\/zh800905003493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3493\/1709399\/zh800905003493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T07:41:43Z","timestamp":1625384503000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/9\/3493\/21240\/A-pathobiologic-pathway-linking-thrombopoietin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-04-1320","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}